
Craig McDonald
Chair, Department of Physical Medicine & Rehabilitation · University of California Davis Health
Credentials: · · · · ·
History
- Present
Department of Physical Medicine & Rehabilitation · University of California Davis Health
- 1991–1992
Neuromuscular Medicine
- 1987–1991
Neurology


Research
Review · The Lancet Neurology · 2010 · 1,430 citations
Review · The Lancet Neurology · 2010 · 804 citations
The Lancet · 2018 · First of 11 authors · Corresponding · 399 citations

30 papers
- PC
29 papers

28 papers

23 papers

22 papers

20 papers

19 papers
- BD
18 papers
Grants
- 2018–2028
NINDS Network for Excellence in Neuroscience: Clinical Research Site at UC Davis
National Institute of Neurological Disorders and Stroke · U24
Contact PI · $3.2M · University of California at Davis
- 2011–2018
NINDS Network for Excellence in Neuroscience: Clinical Research Site at UC Davis
National Institute of Neurological Disorders and Stroke · U10
Contact PI · $1.9M · University of California at Davis
- 2011–2016
Biomarker Discovery and Validation in a Duchenne Dystrophy Natural History Study
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $1.5M · University of California at Davis
- 2011–2016
Clinically Meaningful Outcomes for Duchenne Muscular Dystrophy Therapeutic Trials
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $1.3M · University of California at Davis
Clinical trials
- 2022–2027
Principal investigator · Active not recruiting · Phase 3
Capricor Inc.
- 2018–2020
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Principal investigator · Completed · Phase 2
Capricor Inc.
- 2013–2018
Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
Principal investigator · Completed · Phase 1, Phase 2
Craig McDonald, MD
- 2009–2014
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
Principal investigator · Completed · Phase 3
Santhera Pharmaceuticals


